Company Dr. Reddy's Laboratories Limited NSE India S.E.

Equities

DRREDDY

INE089A01023

Pharmaceuticals

Market Closed - NSE India S.E. 07:43:37 2024-03-18 am EDT 5-day change 1st Jan Change
6,341 INR +0.89% Intraday chart for Dr. Reddy's Laboratories Limited -0.73% +9.37%

Business Summary

Dr. Reddy's Laboratories specializes in developing, producing, and selling pharmaceutical products. Net sales break down by activity as follows:

- sales of generic medications (79.9%): brand-name or generic prescription medications and OTC medicines;

- sales of active ingredients (15.7%). The group also supplies customized pharmaceutical services;

- other (4.4%): sales of generic biopharmaceutical products, development of molecular agents, etc.

Net sales are distributed geographically as follows: India (18.8%), the United States (45%), Russia (9.9%) and other (26.3%).

Number of employees: 25,863

Sales per Business

INR in Million2022Weight2023Weight Delta
Global Generics
86.9 %
179,170 83.6 % 213,768 86.9 % +19.31%
Pharmaceutical Services and Active Ingredients
11.8 %
30,740 14.3 % 29,069 11.8 % -5.44%
Others
1.2 %
2,870 1.3 % 3,042 1.2 % +5.99%

Sales per region

INR in Million2022Weight2023Weight Delta
United States
43.4 %
80,564 37.6 % 106,683 43.4 % +32.42%
Others
27.4 %
68,962 32.2 % 67,469 27.4 % -2.16%
India
20.5 %
43,986 20.5 % 50,499 20.5 % +14.81%
Russia
8.6 %
20,879 9.7 % 21,228 8.6 % +1.67%

Managers

Managers TitleAgeSince
Chief Executive Officer 57 18-04-01
Director of Finance/CFO - 20-11-01
Chairman 56 93-01-17
Chairman 63 86-04-07
Chief Tech/Sci/R&D Officer - 23-07-31
Compliance Officer - 22-03-16
Public Communications Contact 57 17-05-31
Investor Relations Contact - -
Corporate Officer/Principal - -
General Counsel - 21-04-30

Members of the board

Members of the board TitleAgeSince
Chairman 63 86-04-07
Chairman 56 93-01-17
Director/Board Member 73 07-06-04
Director/Board Member 64 19-01-30
Director/Board Member - 23-05-09
Director/Board Member 72 22-07-31
Director/Board Member 63 Dec. 28
Director/Board Member 64 22-01-06
Director/Board Member 61 23-09-18
Director/Board Member - 22-01-27

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 166,867,796 152,626,887 ( 91.47 %) 345,564 ( 0.2071 %) 91.47 %

Shareholders

NameEquities%Valuation
APS Trust
20.59 %
34,345,308 20.59 % 2 659 M ₹
Life Insurance Corporation of India (Investment Portfolio)
5.593 %
9,328,967 5.593 % 722 M ₹
5,523,677 3.312 % 428 M ₹
First Sentier Investors (Australia) IM Ltd.
2.193 %
3,658,520 2.193 % 283 M ₹
HDFC Asset Management Co. Ltd. (Invt Mgmt)
1.650 %
2,752,736 1.650 % 213 M ₹
SBI Funds Management Ltd.
1.590 %
2,652,740 1.590 % 205 M ₹
2,543,418 1.525 % 197 M ₹
GIC Pte Ltd. (Investment Management)
1.241 %
2,070,475 1.241 % 160 M ₹
UTI Asset Management Co. Ltd. (Investment Management)
1.044 %
1,740,606 1.044 % 135 M ₹
1,120,499 0.6718 % 87 M ₹
NameEquities%Valuation
RBC Trust Co. Delaware Ltd.
1.352 %
2,254,449 1.352 % 173 M ₹
BlackRock Advisors LLC
1.308 %
2,182,135 1.308 % 168 M ₹
Renaissance Technologies LLC
1.116 %
1,860,795 1.116 % 143 M ₹
Goldman Sachs Asset Management LP
1.101 %
1,837,163 1.101 % 141 M ₹
Robeco Alternative Investments
1.034 %
1,725,380 1.034 % 132 M ₹
Aikya Investment Management Ltd.
0.6574 %
1,096,573 0.6574 % 84 M ₹
Vanguard Fiduciary Trust Co.
0.6225 %
1,038,258 0.6225 % 80 M ₹
Dimensional Fund Advisors LP
0.4972 %
829,310 0.4972 % 64 M ₹
Morgan Stanley Capital Services LLC
0.4907 %
818,552 0.4907 % 63 M ₹
Numeric Investors LLC
0.4587 %
765,193 0.4587 % 59 M ₹

Company contact information

Dr. Reddy's Laboratories Ltd.

Door No. 8-2-337 Road No. 3

500034, Hyderabad

+91 40 4900 2900

http://www.drreddys.com
address Dr. Reddy's Laboratories Limited(DRREDDY)

Group companies

NameCategory and Sector
Biotechnology
Pharmaceuticals: Major
Biotechnology

Sales per Business

Sales per region

Trading Rating
Investor Rating
ESG Refinitiv
-
More Ratings
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
36
Last Close Price
6,340 INR
Average target price
5,978 INR
Spread / Average Target
-5.72%
Consensus